New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
作者信息
Williams J E
出版信息
J Nucl Med. 1997 Nov;38(11):19N-20N, 26N.
PMID:9374327
Abstract
摘要
相似文献
1
New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
J Nucl Med. 1997 Nov;38(11):19N-20N, 26N.
2
Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
J Nucl Med. 2000 Apr;41(4):688-91.
3
Samarium-153 lexidronam for painful bone metastases.
Med Lett Drugs Ther. 1997 Aug 29;39(1008):83-4.
4
[Radionuclide therapy for painful bone metastases].
Wiad Lek. 2004;57(5-6):280-3.
5
Pain palliation and nuclear medicine.
Eur J Nucl Med. 1993 Jan;20(1):1-3. doi: 10.1007/BF02261237.
6
ESR dosimetry of 89Sr and 153Sm in bone.
Appl Radiat Isot. 2001 Feb;54(2):269-74. doi: 10.1016/s0969-8043(00)00159-7.
7
Molecular radiotherapy.
Clin Med (Lond). 2012 Aug;12(4):381-6. doi: 10.7861/clinmedicine.12-4-381.
8
9
Targeted radionuclide therapy for bone metastases.
Eur J Nucl Med. 1993 Jan;20(1):66-74. doi: 10.1007/BF02261248.
10
Strontium 89 therapy for the palliation of pain due to osseous metastases.
JAMA. 1995 Aug 2;274(5):420-4.
Zotero 插件